Worldwide Variations in Colorectal Cancer

Abstract

Previous studies have documented significant international variations in colorectal cancer rates. However, these studies were limited because they were based on old data or examined only incidence or mortality data. In this article, the colorectal cancer burden and patterns worldwide are described using the most recently updated cancer incidence and mortality data available from the International Agency for Research on Cancer (IARC). The authors provide 5-year (1998-2002), age-standardized colorectal cancer incidence rates for select cancer registries in IARC's Cancer Incidence in Five Continents, and trends in age-standardized death rates by single calendar year for select countries in the World Health Organization mortality database. In addition, available information regarding worldwide colorectal cancer screening initiatives are presented. The highest colorectal cancer incidence rates in 1998-2002 were observed in registries from North America, Oceania, and Europe, including Eastern European countries. These high rates are most likely the result of increases in risk factors associated with "Westernization," such as obesity and physical inactivity. In contrast, the lowest colorectal cancer incidence rates were observed from registries in Asia, Africa, and South America. Colorectal cancer mortality rates have declined in many longstanding as well as newly economically developed countries; however, they continue to increase in some low-resource countries of South America and Eastern Europe. Various screening options for colorectal cancer are available and further international consideration of targeted screening programs and/or recommendations could help alleviate the burden of colorectal cancer worldwide. CA Cancer

Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status

“…Colorectal cancer remains one of the major causes of cancer deaths worldwide 1, 2. Despite recent advances in the development of various diagnostic tools, in many patients, colorectal cancer is still diagnosed at an advanced stage, and recurrent tumors are often detected even after curative surgery.…”

TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo

“…5 Depending on the cell type, TRAIL induces apoptosis independently of p53. 4 Therefore, TRAIL promises to be also effective in CRC despite the high rate of mutated p53 in CRC cells.…”

Current Status and Future Directions in Colorectal Cancer

“…It is thought that Bthe westernized lifestyle^of physical inactivity, poor diet, obesity, and increased alcohol consumption and longterm smoking attribute to this higher burden [4,5]. In contrast, registries in Asia, Africa and South America have some of the lowest rates of CRC [4].…”

“…It is thought that Bthe westernized lifestyle^of physical inactivity, poor diet, obesity, and increased alcohol consumption and longterm smoking attribute to this higher burden [4,5]. In contrast, registries in Asia, Africa and South America have some of the lowest rates of CRC [4]. A review of the 12 population based cancer registries from India (Benaguluru, Barshi, Bhopal, Chennai, Delhi, Mumbai, Ahmedabad, Karunagappally, Kolkata, Nagpur, Pune and Thiruvananthapuram) again demonstrated that the incidence of colon and rectal cancer is significantly lower in India for both genders when compared to the West.…”

“…In the US this can include colonoscopy, fecal occult blood testing, CT colonography, flexible sigmoidoscopy, double contrast barium enema or DNA stool testing. When evaluating colorectal cancer burden worldwide it is important to consider whether screening programs exist as they can transiently increase the incidence of CRC [4]. These numbers will then decrease as more precancerous polyps are detected early before turning into a cancer.…”